Wendy Baughman

3.8k total citations
21 papers, 2.7k citations indexed

About

Wendy Baughman is a scholar working on Epidemiology, Microbiology and Infectious Diseases. According to data from OpenAlex, Wendy Baughman has authored 21 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 6 papers in Microbiology and 5 papers in Infectious Diseases. Recurrent topics in Wendy Baughman's work include Pneumonia and Respiratory Infections (14 papers), Respiratory viral infections research (6 papers) and Pneumocystis jirovecii pneumonia detection and treatment (6 papers). Wendy Baughman is often cited by papers focused on Pneumonia and Respiratory Infections (14 papers), Respiratory viral infections research (6 papers) and Pneumocystis jirovecii pneumonia detection and treatment (6 papers). Wendy Baughman collaborates with scholars based in United States, Australia and Israel. Wendy Baughman's co-authors include Monica M. Farley, Mary E. Brandt, Rana Hajjeh, Richard R. Facklam, David S. Stephens, Anne Schuchat, D. S. Stephens, Robert W. Pinner, Arthur Reingold and Richard J. Hamill and has published in prestigious journals such as New England Journal of Medicine, The Lancet and PEDIATRICS.

In The Last Decade

Wendy Baughman

21 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wendy Baughman United States 19 2.2k 1.2k 492 341 172 21 2.7k
James I. Ito United States 28 2.4k 1.1× 2.0k 1.6× 379 0.8× 225 0.7× 382 2.2× 57 5.4k
F. Crokaert Belgium 20 2.2k 1.0× 2.1k 1.7× 153 0.3× 116 0.3× 357 2.1× 81 3.7k
Tsuyoshi Nagatake Japan 30 1.2k 0.5× 841 0.7× 454 0.9× 490 1.4× 496 2.9× 147 2.9k
Kamal Hamed United States 29 978 0.5× 816 0.7× 154 0.3× 562 1.6× 146 0.8× 117 2.2k
Miguel Salavert Spain 29 1.7k 0.8× 1.6k 1.3× 68 0.1× 249 0.7× 234 1.4× 202 3.0k
Catherine Lexau United States 15 3.7k 1.7× 558 0.4× 1.6k 3.3× 423 1.2× 257 1.5× 19 4.3k
Jill Beyer United States 31 1.5k 0.7× 938 0.8× 143 0.3× 247 0.7× 325 1.9× 62 2.8k
J. Carl Craft United States 25 755 0.3× 567 0.5× 217 0.4× 282 0.8× 117 0.7× 46 1.7k
Marı́a Elena Santolaya Chile 29 1.7k 0.8× 1.0k 0.8× 429 0.9× 240 0.7× 240 1.4× 99 2.9k
Shunji Takakura Japan 32 1.4k 0.6× 1.2k 1.0× 122 0.2× 233 0.7× 132 0.8× 102 2.9k

Countries citing papers authored by Wendy Baughman

Since Specialization
Citations

This map shows the geographic impact of Wendy Baughman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendy Baughman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendy Baughman more than expected).

Fields of papers citing papers by Wendy Baughman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wendy Baughman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendy Baughman. The network helps show where Wendy Baughman may publish in the future.

Co-authorship network of co-authors of Wendy Baughman

This figure shows the co-authorship network connecting the top 25 collaborators of Wendy Baughman. A scholar is included among the top collaborators of Wendy Baughman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wendy Baughman. Wendy Baughman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sharma, Dolly, Emily K. Crispell, Wendy Baughman, et al.. (2015). Decline in Pneumococcal Nasopharyngeal Carriage of Vaccine Serotypes After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Children in Atlanta, Georgia. The Pediatric Infectious Disease Journal. 34(11). 1168–1174. 95 indexed citations
2.
Spicer, Jennifer O., et al.. (2013). Socioeconomic and Racial Disparities of Pediatric Invasive Pneumococcal Disease After the Introduction of the 7-valent Pneumococcal Conjugate Vaccine. The Pediatric Infectious Disease Journal. 33(2). 158–164. 12 indexed citations
3.
Sharma, Dolly, Wendy Baughman, Stephanie Thomas, et al.. (2012). Pneumococcal Carriage and Invasive Disease in Children Before Introduction of the 13-valent Conjugate Vaccine. The Pediatric Infectious Disease Journal. 32(2). e45–e53. 68 indexed citations
4.
Lockhart, Shawn R., Naureen Iqbal, Angela A. Cleveland, et al.. (2012). Species Identification and Antifungal Susceptibility Testing of Candida Bloodstream Isolates from Population-Based Surveillance Studies in Two U.S. Cities from 2008 to 2011. Journal of Clinical Microbiology. 50(11). 3435–3442. 239 indexed citations
5.
Adamkiewicz, Thomas V., Benjamin J. Silk, Wendy Baughman, et al.. (2008). Effectiveness of the 7-Valent Pneumococcal Conjugate Vaccine in Children With Sickle Cell Disease in the First Decade of Life. PEDIATRICS. 121(3). 562–569. 128 indexed citations
6.
Albrich, Werner C., Wendy Baughman, Brian Schmotzer, & Monica M. Farley. (2007). Changing Characteristics of Invasive Pneumococcal Disease in Metropolitan Atlanta, Georgia, after Introduction of a 7-Valent Pneumococcal Conjugate Vaccine. Clinical Infectious Diseases. 44(12). 1569–1576. 92 indexed citations
7.
Haber, Michael, Albert E. Barskey, Wendy Baughman, et al.. (2007). Herd immunity and pneumococcal conjugate vaccine: A quantitative model. Vaccine. 25(29). 5390–5398. 60 indexed citations
8.
Stephens, David S., Susu M. Zughaier, Cynthia G. Whitney, et al.. (2005). Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: population-based assessment. The Lancet. 365(9462). 855–863. 133 indexed citations
9.
Mirza, Sara A., Maureen Phelan, David Rimland, et al.. (2003). The Changing Epidemiology of Cryptococcosis: An Update from Population‐Based Active Surveillance in 2 Large Metropolitan Areas, 1992–2000. Clinical Infectious Diseases. 36(6). 789–794. 340 indexed citations
10.
Beneden, Chris Van, Catherine Lexau, Wendy Baughman, et al.. (2003). Aggregated Antibiograms and Monitoring of Drug-ResistantStreptococcus pneumoniae. Emerging infectious diseases. 9(9). 1089–1095. 24 indexed citations
11.
Kellerman, Scott, Katherine McCombs, Wendy Baughman, et al.. (2002). Genotype‐Specific Carriage ofNeisseria meningitidisin Georgia Counties with Hyper‐ and Hyposporadic Rates of Meningococcal Disease. The Journal of Infectious Diseases. 186(1). 40–48. 42 indexed citations
12.
Gay, Kathryn, Wendy Baughman, Yoon K. Miller, et al.. (2000). The Emergence ofStreptococcus pneumoniaeResistant to Macrolide Antimicrobial Agents: A 6‐Year Population‐Based Assessment. The Journal of Infectious Diseases. 182(5). 1417–1424. 106 indexed citations
13.
Hajjeh, Rana, Laura A. Conn, David S. Stephens, et al.. (1999). Cryptococcosis: Population‐Based Multistate Active Surveillance and Risk Factors in Human Immunodeficiency Virus–Infected Persons. The Journal of Infectious Diseases. 179(2). 449–454. 204 indexed citations
14.
Yusuf, H., Roger Rochat, Wendy Baughman, et al.. (1999). Maternal cigarette smoking and invasive meningococcal disease: a cohort study among young children in metropolitan Atlanta, 1989-1996.. American Journal of Public Health. 89(5). 712–717. 43 indexed citations
15.
Kao, A. S., Mary E. Brandt, Laura A. Conn, et al.. (1999). The Epidemiology of Candidemia in Two United States Cities: Results of a Population-Based Active Surveillance. Clinical Infectious Diseases. 29(5). 1164–1170. 381 indexed citations
16.
Reeves, Michael, Gloria W. Ajello, Wendy Baughman, et al.. (1997). Molecular Epidemiology of Sporadic (Endemic) Serogroup C Meningococcal Disease. The Journal of Infectious Diseases. 176(5). 1277–1284. 29 indexed citations
17.
Blumberg, Henry M., David S. Stephens, M E Erwin, et al.. (1996). Invasive Group B Streptococcal Disease: The Emergence of Serotype V. The Journal of Infectious Diseases. 173(2). 365–373. 169 indexed citations
18.
Brandt, Mary E., Lori Hutwagner, Wendy Baughman, et al.. (1996). Molecular subtype distribution of Cryptococcus neoformans in four areas of the United States. Cryptococcal Disease Active Surveillance Group. Journal of Clinical Microbiology. 34(4). 912–917. 87 indexed citations
19.
Hofmann, J., Martín S. Cetron, Monica M. Farley, et al.. (1995). The Prevalence of Drug-ResistantStreptococcus pneumoniaeIn Atlanta. New England Journal of Medicine. 333(8). 481–486. 411 indexed citations
20.
Scouten, William H., et al.. (1974). N-dansylaziridine: A new fluorescent modification for cysteine thiols. Biochimica et Biophysica Acta (BBA) - Protein Structure. 336(2). 421–426. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026